Goseki N, Maruyama M, Nagai K, Kando F, Endo M, Shimoju K, Wada Y
First Dept. of Surgery, Tokyo Medical and Dental University School of Medicine.
Gan To Kagaku Ryoho. 1995 Jul;22(8):1028-35.
Methionine-depleting total parenteral nutrition (Met-deplete TPN), infusing AO-90 amino acid solution (lacking both L-methionine and L-cysteine) as a sole nitrogen source, showed synergistic effects with several antineoplastics including 5-fluorouracil (5-FU). In the recent multi-center, randomized, controlled study, advanced gastric cancer patients were randomly allocated to RT group and Control group. RT group received AO-90 amino acid solution, while Control group infused Amiparen (commercial methionine and cysteine containing amino acid solution) as protein source for 14 days' TPN with 5-FU and mitomycin C (MMC). The over all clinical response rate (PR+CR) in RT and Control groups were 26.3% and 8.1%, respectively, with significant statistical difference in both values at p = 0.015. Fourteen advanced gastric cancer patients allocated to RT and Control group randomly and received each amino acid as protein source for 7 days TPN with 5-FU administration. All cases were performed gastrectomy without waiting period, and resected material was examined the histological response. In the 7 cases of RT group, grade 2 was seen in 4 cases, grade 1-b in 1, grade 1-a in 1 and grade 0 in 1. In the 7 of Control, 3 cases were grade 1-a and the remaining 4 were grade 0. There were significant differences in both degree and incidence of the histological response at p = 0.016. A stage IV gastric cancer patient with marked liver metastasis received 2 times RT therapy with 5-FU and MMC for 14 days and undertaken gastrectomy after 22 day, waiting period. Resected gastric cancer showed grade 2 to 3 histological response, and the liver metastasis showed marked effect as PR to CR.
蛋氨酸消耗型全胃肠外营养(Met-deplete TPN),输注AO-90氨基酸溶液(缺乏L-蛋氨酸和L-半胱氨酸)作为唯一氮源,显示出与包括5-氟尿嘧啶(5-FU)在内的多种抗肿瘤药物具有协同作用。在最近的一项多中心、随机、对照研究中,晚期胃癌患者被随机分配到放疗组和对照组。放疗组接受AO-90氨基酸溶液,而对照组输注氨复命(含蛋氨酸和半胱氨酸的市售氨基酸溶液)作为蛋白质来源,进行为期14天的TPN,并联合5-FU和丝裂霉素C(MMC)。放疗组和对照组的总体临床缓解率(PR+CR)分别为26.3%和8.1%,两者差异具有显著统计学意义,p = 0.015。14例晚期胃癌患者随机分配到放疗组和对照组,接受每种氨基酸作为蛋白质来源,进行为期7天的TPN并给予5-FU。所有病例均立即进行胃切除术,切除的材料进行组织学反应检查。放疗组的7例患者中,4例为2级,1例为1-b级,1例为1-a级,1例为0级。对照组的7例患者中,3例为1-a级,其余4例为0级。组织学反应的程度和发生率均有显著差异,p = 0.016。一名伴有明显肝转移的IV期胃癌患者接受了2次放疗,联合5-FU和MMC治疗14天,22天等待期后进行胃切除术。切除的胃癌显示出2至3级组织学反应,肝转移显示出显著效果,达到PR至CR。